抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產品編號 | 圖片 | 產品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
Trelagliptin (succinate)，99% | C22H26FN5O6 | |||
|
|
|||||
|
Calpain Inhibitor I，95% | C20H37N3O4 | |||
|
|
|||||
|
Omarigliptin，99% | C17H20F2N4O3S | |||
|
|
|||||
|
Bivalirudin，98% | C98H138N24O33 | |||
|
|
|||||
|
Batimastat (BB-94)，98% | C23H31N3O4S2 | |||
|
|
|||||
|
Ilomastat，95% | C20H28N4O4 | |||
|
|
|||||
|
CA-074 ME，98% | C19H31N3O6 | |||
|
|
|||||
|
Marimastat，95% | C15H29N3O5 | |||
|
|
|||||
|
PD 151746,非肽鈣蛋白酶抑制劑，≥95% | C11H8FNO2S | |||
|
|
|||||
|
Dabigatran (BIBR 953)，95%(HPLC) | C25H25N7O3 | |||
|
|
|||||
|
SB 3CT，97% | C15H14O3S2 | |||
|
|
|||||
|
Eltrombopag (Olamine)，98% | C29H36N6O6 | |||
|
|
|||||
|
Odanacatib (MK-0822)，99% | C25H27F4N3O3S | |||
|
|
|||||
|
Argatroban，98% | C23H36N6O5S | |||
|
|
|||||
|
Teneligliptin Hydrobromide (2:5)，99% | C22H32.5Br2.5N6OS | |||
|
|
|||||
|
GK921，98% | C21H20N4O | |||
|
|
|||||
|
DBPR108，98% | C16H25FN4O2 | |||
|
|
|||||
|
NQ301，98% | C18H12ClNO3 | |||
|
|
|||||
|
VBY-825，98% | C23H29F4N3O5S | |||
|
|
|||||
|
CA-074，98% | C18H29N3O6 | |||
|
|
|||||
